SARS-CoV-2; COVID-19; pandemics; biomedical research; neoplasms; clinical trials as topic; telemedicine
Allergy and Immunology | Medical Pharmacology | Oncology
Cancer patients need access to promising investigational therapies, available only through clinical trials, and the emergence of COVID-19 and the resulting pandemic became an emerging threat to fulfilling that need. Many academic medical centers were pausing their clinical research programs, diverting their resources and sheltering their teams. Sarah Cannon, the Cancer Institute of HCA Healthcare, made the decision to stay safe, but stay the course.
"Research Amidst the Pandemic,"
HCA Healthcare Journal of Medicine: Vol. 1:
0, Article 3.
Available at: https://scholarlycommons.hcahealthcare.com/hcahealthcarejournal/vol1/iss0/3